Lee In A, Moon Gilseong, Kang Seokmin, Lee Kang Hee, Lee Sun Min, Kim Jin Kyong, Lee Cho Rok, Kang Sang-Wook, Jeong Jong Ju, Nam Kee-Hyun, Chung Woong Youn
Department of Surgery, College of Medicine, Severance Hospital, Yonsei University, Seoul 03722, Korea.
Department of Surgery, Yongin Severance Hospital, Yongin-si 16995, Korea.
Cancers (Basel). 2022 Jun 2;14(11):2757. doi: 10.3390/cancers14112757.
The diagnostic and treatment rates of early thyroid cancer have been increasing, including those of aggressive variants of papillary thyroid cancer (AVPTC). This study aimed to analyze the need for completion total thyroidectomy after lobectomy for clinically low-to-intermediate-risk AVPTC. Overall, 249 patients who underwent hemithyroidectomy (HT, n = 46) or bilateral total thyroidectomy (BTT, n = 203) for AVPTC between November 2005 and December 2019 at our single institution were examined. The average follow-up period was 14.9 years, with a recurrence rate of 4.3% and 10.8% in the HT and BTT groups, respectively. Multivariate Cox analysis revealed that palpable tumor on the neck during evaluation (HR, 2.7; 95% CI, 1.1-6.4; = 0.025), clinical N1b (HR, 8.3; 95% CI, 1.1-63.4; = 0.041), tumor size (cm) (HR, 1.3; 95% CI, 1.0-1.7; = 0.036), gross extrathyroidal extension (HR, 3.1; 95% CI, 1.4-7.0; = 0.007), and pathologic T3b (HR, 3.4; 95% CI, 1.0-11.4; = 0.045) or T4a (HR, 6.0; 95% CI, 1.9-18.8; = 0.002) were associated with an increased risk of recurrence. Incidentalomas identified during diagnosis had a significantly lower risk of recurrence (HR, 0.4; 95% CI, 0.2-0.9; = 0.033). Close follow-up may be performed without completion total thyroidectomy for AVPTC found incidentally after HT.
早期甲状腺癌的诊断和治疗率一直在上升,包括甲状腺乳头状癌侵袭性变体(AVPTC)。本研究旨在分析临床低至中风险AVPTC行甲状腺叶切除术后行甲状腺全切除术的必要性。总体而言,对2005年11月至2019年12月期间在我们单一机构因AVPTC接受甲状腺半切术(HT,n = 46)或双侧甲状腺全切除术(BTT,n = 203)的249例患者进行了检查。平均随访期为14.9年,HT组和BTT组的复发率分别为4.3%和10.8%。多因素Cox分析显示,评估时颈部可触及肿瘤(HR,2.7;95%CI,1.1 - 6.4;P = 0.025)、临床N1b(HR,8.3;95%CI,1.1 - 63.4;P = 0.041)、肿瘤大小(cm)(HR,1.3;95%CI,1.0 - 1.7;P = 0.036)、肉眼可见的甲状腺外侵犯(HR,3.1;95%CI,1.4 - 7.0;P = 0.007)以及病理T3b(HR,3.4;95%CI,1.0 - 11.4;P = 0.045)或T4a(HR,6.0;95%CI,1.9 - 18.8;P = 0.002)与复发风险增加相关。诊断时发现的偶发瘤复发风险显著较低(HR,0.4;95%CI,0.2 - 0.9;P = 0.033)。对于HT术后偶然发现的AVPTC,若密切随访,可不进行甲状腺全切除术。